therapy < there < thereafter

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references

Number of relevant bibliographic references: 51.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000005 (2020)	Tadeusz Płusa	[Options for controlling new Corona virus infection - 2019-nCoV].
000006 (2020)	Anna Jakubczyc ; Claus Neurohr	[Interstitial lung disease in rheumatic diseases - new therapeutic approaches].
000016 (2020)	M. Silberstein	Vitamin D: A simpler alternative to tocilizumab for trial in COVID-19?
000039 (2020)	Hsien-Fu Chiu [Taïwan] ; Mei-Chin Wen [Taïwan] ; Ming-Ju Wu [Taïwan] ; Cheng-Hsu Chen [Taïwan] ; Tung-Min Yu [Taïwan] ; Ya-Wen Chuang [Taïwan] ; Shih-Ting Huang [Taïwan] ; Shang-Feng Tsai [Taïwan] ; Ying-Chih Lo [Taïwan] ; Hao-Chung Ho [Taïwan] ; Kuo-Hsiung Shu [Taïwan]	Treatment of chronic active antibody-mediated rejection in renal transplant recipients – a single center retrospective study
000042 (2020)	Prakhar Vijayvargiya [États-Unis] ; Zerelda Esquer Garrigos [États-Unis] ; Natalia E. Castillo Almeida [États-Unis] ; Pooja R. Gurram [États-Unis] ; Ryan W. Stevens [États-Unis] ; Raymund R. Razonable [États-Unis]	Treatment Considerations for COVID-19: A Critical Review of the Evidence (or Lack Thereof)
000061 (2020)	Ver Nica Cantarín-Extremera [Espagne] ; María Jiménez-Legido [Espagne] ; Anna Duat-Rodríguez [Espagne] ; Marta García-Fernández [Espagne] ; Nelmar Valentina Ortiz-Cabrera [Espagne] ; María Luz Ruiz-Falc Rojas [Espagne] ; Luis González-Gutiérrez-Solana [Espagne]	Tocilizumab in pediatric refractory status epilepticus and acute epilepsy: Experience in two patients.
000079 (2020)	Caterina Vacchi [Italie] ; Marco Sebastiani [Italie] ; Giulia Cassone [Italie] ; Stefania Cerri [Italie] ; Giovanni Della Casa [Italie] ; Carlo Salvarani [Italie] ; Andreina Manfredi [Italie]	Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review
000097 (2020)	Weiyi Tan ; Jamil Aboulhosn	The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease
000101 (2020)	Mohammed Shah ; Derek M. Yellon ; Sean M. Davidson	The Role of Extracellular DNA and Histones in Ischaemia-Reperfusion Injury of the Myocardium
000105 (2020)	Peter J. Hotez ; Maria Elena Bottazzi ; David B. Corry	The Potential Role of Th17 Immune Responses in Coronavirus Immunopathology and Vaccine-induced Immune Enhancement
000116 (2020)	Xi-Ying Wang [République populaire de Chine] ; Fen Zhang [République populaire de Chine] ; Chi Zhang [République populaire de Chine] ; Liang-Rong Zheng [République populaire de Chine] ; Jian Yang [République populaire de Chine]	The Biomarkers for Acute Myocardial Infarction and Heart Failure
000122 (2020)	Timothy M. Smith ; Anuj Tharakan ; Rebecca K. Martin	Targeting ADAM10 in Cancer and Autoimmunity
000134 (2020)	Ayush Gupta [Inde] ; Narendra Kumar Bagri [Inde] ; Saroj Kumar Tripathy [Inde] ; Adarsh Barwad [Inde] ; Ravi Hari Phulware [Inde] ; Pankaj Hari [Inde]	Successful use of tocilizumab in amyloidosis secondary to systemic juvenile idiopathic arthritis.
000141 (2020)	Adam Amlani [Canada] ; Claire Barber [Canada] ; Aurore Fifi-Mah [Canada] ; Jose Monzon [Canada]	Successful Treatment of Cytokine Release Syndrome with IL-6 Blockade in a Patient Transitioning from Immune-Checkpoint to MEK/BRAF Inhibition: A Case Report and Review of Literature.
000146 (2020)	Francis F. Furia [Tanzanie] ; Evance Godfrey [Tanzanie] ; Naomi Mwamanenge [Tanzanie] ; Peter Swai [Tanzanie]	Spectrum of paediatric rheumatic disorders at a tertiary hospital in Tanzania
000183 (2020)	Ibai Los-Arcos [Espagne] ; Juan Aguilar-Company [Espagne] ; Isabel Ruiz-Camps [Espagne]	Risk of infection associated with new therapies for lymphoproliferative syndromes.
000207 (2020)	Shengyu Zhang ; Lei Li ; Aizong Shen ; Yongwu Chen ; Zhigang Qi	Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia
000221 (2020)	Yao-Chung Liu [Taïwan] ; Ting-An Lin [Taïwan] ; Hao-Yuan Wang [Taïwan] ; Po-Shen Ko [Taïwan] ; Chia-Jen Liu [Taïwan] ; Liang-Tsai Hsiao [Taïwan] ; Sheng-Hsuan Chien [Taïwan] ; Jyh-Pyng Gau [Taïwan]	Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report
000225 (2020)	Ali Rismanbaf [Iran]	Potential Treatments for COVID-19; a Narrative Literature Review
000233 (2020)	Giulia Cassone [Italie] ; Marco Sebastiani [Italie] ; Caterina Vacchi [Italie] ; Stefania Cerri [Italie] ; Carlo Salvarani [Italie] ; Andreina Manfredi [Italie]	Pirfenidone for the treatment of interstitial lung disease associated to rheumatoid arthritis: a new scenario is coming?
000249 (2020)	Mark P. Lythgoe [Royaume-Uni] ; Paul Middleton [Royaume-Uni]	Ongoing Clinical Trials for the Management of the COVID-19 Pandemic

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "there" 

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "there" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    there
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021